Metastatic Colorectal Cancer Market
Metastatic Colorectal Cancer Market Analysis, By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiotherapy, and Combination Therapy), By Route of Administration (Oral and Intravenous), By Therapy Mode (Single Dose Administration and Multi Dose Administration), By Age Group (Children, Adults, and Geriatric), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Rehab Care), and Region - Market Insights 2024 to 2034
Analysis of Metastatic Colorectal Cancer Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT10459MR
- 30 Oct 2024
- Healthcare
- 170 Pages
- Tables
- Figures
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, Including Taxonomy and Market Definition
- 3. Global Market Trends and Success Factors, Including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, Including Historical Analysis and Future Projections
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 5.1. Treatment Type
- 5.2. Route of Administration
- 5.3. Therapy Mode
- 5.4. Age Group
- 5.5. End User
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Treatment Type
- 6.1. Chemotherapy
- 6.2. Targeted Therapy
- 6.3. Immunotherapy
- 6.4. Radiotherapy
- 6.5. Combination Therapy
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration
- 7.1. Oral
- 7.2. Intravenous
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy Mode
- 8.1. Single Dose Administration
- 8.2. Multi Dose Administration
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Age Group
- 9.1. Children
- 9.2. Adults
- 9.3. Geriatric
- 9.4. Community/Specialty Clinics
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
- 10.1. Hospitals
- 10.2. Specialty Clinics
- 10.3. Ambulatory Surgical Centers
- 10.4. Rehab Care
- 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Western Europe
- 11.4. Eastern Europe
- 11.5. East Asia
- 11.6. South Asia & Pacific
- 11.7. MEA
- 12. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 13. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 19. Sales Forecast 2024 to 2034 by Treatment Type, Route of Administration, Therapy Mode, Age Group, and End User for 30 Countries
- 20. Competition Outlook, Including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 21. Company Profile
- 21.1. Pfizer
- 21.2. Sanofi
- 21.3. Taiho Pharma
- 21.4. Ono Pharma
- 21.5. Hutchison Medipharma
- 21.6. Isofol Medical
- 21.7. Sumitomo Dainippon Pharma
- 21.8. G1 Therapeutics
- 21.9. Merck & Co
- 21.10. Bristol-Myers Squibb Co
- 21.11. Daiichi Sankyo/AstraZeneca
- 21.12. Eli Lilly and Company
- 21.13. Mirati Therapeutics
- 21.14. Cardiff Oncology
- 21.15. Abbott Laboratories
- 21.16. Epigenomics AG
- 22. Assumptions & Acronyms Used
- 23. Research Methodology & Data Sources
Metastatic Colorectal Cancer Market